Cargando…

Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice

Detalles Bibliográficos
Autores principales: Shankaranarayanan, Jayanth Suryanarayanan, Kanwar, Jagat R., AL-Juhaishi, Afrah Jalil Abd, Kanwar, Rupinder K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483985/
https://www.ncbi.nlm.nih.gov/pubmed/31024014
http://dx.doi.org/10.1038/s41598-019-42459-5
_version_ 1783414043364556800
author Shankaranarayanan, Jayanth Suryanarayanan
Kanwar, Jagat R.
AL-Juhaishi, Afrah Jalil Abd
Kanwar, Rupinder K.
author_facet Shankaranarayanan, Jayanth Suryanarayanan
Kanwar, Jagat R.
AL-Juhaishi, Afrah Jalil Abd
Kanwar, Rupinder K.
author_sort Shankaranarayanan, Jayanth Suryanarayanan
collection PubMed
description
format Online
Article
Text
id pubmed-6483985
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64839852019-05-07 Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice Shankaranarayanan, Jayanth Suryanarayanan Kanwar, Jagat R. AL-Juhaishi, Afrah Jalil Abd Kanwar, Rupinder K. Sci Rep Author Correction Nature Publishing Group UK 2019-04-25 /pmc/articles/PMC6483985/ /pubmed/31024014 http://dx.doi.org/10.1038/s41598-019-42459-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Shankaranarayanan, Jayanth Suryanarayanan
Kanwar, Jagat R.
AL-Juhaishi, Afrah Jalil Abd
Kanwar, Rupinder K.
Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title_full Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title_fullStr Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title_full_unstemmed Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title_short Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
title_sort author correction: doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in tramp mice
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483985/
https://www.ncbi.nlm.nih.gov/pubmed/31024014
http://dx.doi.org/10.1038/s41598-019-42459-5
work_keys_str_mv AT shankaranarayananjayanthsuryanarayanan authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice
AT kanwarjagatr authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice
AT aljuhaishiafrahjalilabd authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice
AT kanwarrupinderk authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice